Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $11.6B | $14.5B | $15.0B | $14.2B | $14.7B | $13.9B | $13.2B | $13.3B | $14.9B | $17.1B | $18.1B | $18.1B | $17.8B | $20.2B | $22.4B | $33.8B | $36.0B | $40.0B | $47.0B | $157.3B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Elevance Health Inc.'s last 12-month Gross Profit is $76.7B, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Elevance Health Inc.'s Gross Profit growth was 63.2%. The average annual Gross Profit growth rates for Elevance Health Inc. have been 31.5% over the past three years, 27.9% over the past five years.
Over the last year, Elevance Health Inc.'s Gross Profit growth was 63.2%, which is higher than industry growth of 2.0%. It indicates that Elevance Health Inc.'s Gross Profit growth is Good.